Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Talisule Granule is a proprietary Ayurvedic polyherbal formulation developed and manufactured by Kottakkal Arya Vaidya Sala. Presented in an improved granule dosage form for better palatability and easier administration compared to traditional powders, its primary active ingredient is Talisapatra (Abies spectabilis), complemented by Chavika and approximately ten other herbal components. It is clinically indicated for the management of upper respiratory tract infections, sinusitis, cough, asthma, bronchitis, and allergic conditions, as well as anorexia. The formulation functions as an expectorant and anti-inflammatory agent, soothing the mucosal membranes and modulating immune responses. According to Ayurvedic principles, it works by balancing the Kapha and Vata doshas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Talisule Granule.